{"nct_id":"NCT02985957","title":"A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2017-03-26","start_date_type":"ACTUAL","primary_completion_date":"2022-04-05","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}